Form 4: Aardvark Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Nelson Sun, See Remarks of Aardvark Therapeutics, Inc., sold 76,754 shares of common stock on September 10, 2026.
Summary
- Open-market sale: disposed of 14,754 Common Stock, par value $0.00001 per share at $5.00 ($73,779) on September 10, 2026; holds 97,475 after (Direct).
- Open-market sale: disposed of 62,000 Common Stock, par value $0.00001 per share at $5.18 ($321,179) on September 11, 2026; holds 35,475 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $394,957 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Nelson Sun — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Common Stock, par value $0.00001 per share | 14,754 | $5 | $73.8K | 97,475 |
| 2026-09-11 | Open-market sale | Common Stock, par value $0.00001 per share | 62,000 | $5 | $321.2K | 35,475 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (14,754 shares) |
| 2026-09-11 | Open-market sale (62,000 shares) |
Keywords
insider transaction, Form 4, AARD, Aardvark Therapeutics, Inc., bearish, Nelson Sun
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.